Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Protein tyrosine phosphorylation accompanies and is essential for integrin signaling. We have shown that tyrosine phosphorylation of paxillin α and Crk-associated substrate (p130 Cas ) is a prominent event on integrin activation in normal murine mammary gland epithelial cells. Tyrosine phosphorylation of p130 Cas has been demonstrated to facilitate cell migration. We show here that tyrosine phosphorylation of paxillin α acts to reduce haptotactic cell migrations as well as transcellular invasive activities in several different experimental cell systems, whereas tyrosine phosphorylation of p130 Cas exerts opposing effects to those of paxillin α. Each of the phosphorylation-null mutants acts as a dominant negative for each phenotype. Moreover, we found that overexpression of paxillin α reduced the cell saturation density of normal murine mammary gland cells, whereas overexpression of p130 Cas increased it. These effects also seemed to depend on tyrosine phosphorylation events. Cell growth rates and morphologies at growing phases were not significantly altered, nor were cells transformed. Addition of epidermal growth factor increased saturation density of the paxillin α-overexpressing cells, whereas no further increment was observed in p130 Cas -overexpressing cells. We propose that tyrosine phosphorylation of paxillin α and p130 Cas exerts opposing effects on several integrin-mediated cellular events, possibly through different signaling pathways.

Bibliography

Yano, H., Uchida, H., Iwasaki, T., Mukai, M., Akedo, H., Nakamura, K., Hashimoto, S., & Sabe, H. (2000). Paxillin α and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. Proceedings of the National Academy of Sciences, 97(16), 9076–9081.

Authors 8
  1. Hajime Yano (first)
  2. Hiroshi Uchida (additional)
  3. Teruo Iwasaki (additional)
  4. Mutsuko Mukai (additional)
  5. Hitoshi Akedo (additional)
  6. Kuniaki Nakamura (additional)
  7. Shigeru Hashimoto (additional)
  8. Hisataka Sabe (additional)
References 50 Referenced 76
  1. 10.1016/0092-8674(92)90115-S
  2. 10.1016/S0092-8674(00)81280-5
  3. 10.1016/S0962-8924(98)80005-6
  4. Nakamura K. Yano H. Uchida H. Hashimoto S. Schaefer E. & Sabe H. J. (2000) J. Biol. Chem. in press.
  5. 10.1002/j.1460-2075.1994.tb06684.x
  6. 10.1016/0092-8674(93)90404-E
  7. 10.1128/MCB.16.6.2606
  8. 10.1128/MCB.17.3.1702
  9. 10.1083/jcb.140.1.211
  10. 10.1083/jcb.140.4.961
  11. 10.1083/jcb.146.2.389
  12. 10.1126/science.7716514
  13. 10.1016/S1357-2725(98)00062-4
  14. 10.1083/jcb.119.4.893
  15. 10.1128/MCB.17.12.6906
  16. 10.1083/jcb.127.4.1139
  17. 10.1074/jbc.270.29.17437
  18. 10.1038/376267a0
  19. 10.1083/jcb.127.6.2021
  20. H Akedo, K Shinkai, M Mukai, Y Mori, R Tateishi, K Tanaka, R Yamamoto, T Morishita Cancer Res 46, 2416–2422 (1986). / Cancer Res by Akedo H (1986)
  21. 10.1091/mbc.11.4.1315
  22. 10.1002/(SICI)1097-0215(19990611)81:6<918::AID-IJC13>3.0.CO;2-E
  23. 10.1074/jbc.273.35.22435
  24. 10.1016/S0960-9822(95)00060-1
  25. 10.1073/pnas.90.18.8392
  26. 10.1074/jbc.273.9.5146
  27. 10.1128/MCB.19.4.2763
  28. 10.1073/pnas.91.9.3984
  29. 10.1074/jbc.271.15.8959
  30. 10.1074/jbc.270.49.29145
  31. 10.1074/jbc.272.44.27660
  32. 10.1083/jcb.148.5.957
  33. 10.1038/332272a0
  34. 10.1083/jcb.108.6.2401
  35. 10.1083/jcb.111.3.1059
  36. 10.1073/pnas.90.18.8319
  37. 10.1126/science.7652575
  38. 10.1074/jbc.272.49.30688
  39. 10.1083/jcb.137.2.481
  40. 10.1083/jcb.147.7.1561
  41. 10.1074/jbc.272.41.25993
  42. 10.1016/S0167-4889(98)00157-8
  43. 10.1074/jbc.272.14.9363
  44. 10.1016/S0021-9258(17)42406-9
  45. 10.1016/S1357-2725(99)00015-1
  46. 10.1152/physrev.1999.79.4.1283
  47. 10.1006/bbrc.1996.0745
  48. 10.1128/mcb.13.8.4648-4656.1993
  49. 10.1074/jbc.270.52.31219
  50. 10.1074/jbc.274.5.3001
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:41 a.m.)
Deposited 3 years, 4 months ago (April 13, 2022, 5:25 p.m.)
Indexed 11 months, 3 weeks ago (Sept. 7, 2024, 5:52 a.m.)
Issued 25 years, 1 month ago (Aug. 1, 2000)
Published 25 years, 1 month ago (Aug. 1, 2000)
Published Online 25 years, 1 month ago (Aug. 1, 2000)
Published Print 25 years, 1 month ago (Aug. 1, 2000)
Funders 0

None

@article{Yano_2000, title={Paxillin α and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation}, volume={97}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.97.16.9076}, DOI={10.1073/pnas.97.16.9076}, number={16}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Yano, Hajime and Uchida, Hiroshi and Iwasaki, Teruo and Mukai, Mutsuko and Akedo, Hitoshi and Nakamura, Kuniaki and Hashimoto, Shigeru and Sabe, Hisataka}, year={2000}, month=aug, pages={9076–9081} }